Equities

Auxly Cannabis Group Inc

Auxly Cannabis Group Inc

Actions
  • Price (EUR)0.037
  • Today's Change-0.001 / -3.65%
  • Shares traded25.00k
  • 1 Year change+210.92%
  • Beta--
Data delayed at least 15 minutes, as of May 03 2024 19:48 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Auxly Cannabis Group Inc. is a Canada-based consumer packaged goods company in the cannabis products market. The Company is focused on developing, manufacturing and distributing branded cannabis products. The Company's brands include Parcel, Back Forty, Foray, Dosecann and Kolab Project. It provides various products, including vaporizers, edibles, dried flowers, pre-rolls, capsules and oils and concentrates. The Company's subsidiaries include Auxly Charlottetown Inc., Auxly Ottawa Inc., Auxly Annapolis Inc., Auxly Annapolis OG Inc., and Auxly Leamington Inc.

  • Revenue in CAD (TTM)101.08m
  • Net income in CAD-44.51m
  • Incorporated1987
  • Employees369.00
  • Location
    Auxly Cannabis Group Inc777 Richmond St. W, Unit 002TORONTO M6J 0C2CanadaCAN
  • Phone+1 (647) 812-0121
  • Fax+1 (416) 863-1716
  • Websitehttps://www.auxly.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.